撒哈拉以南非洲的癌症护理患者导航:一个范围审查
Elizabeth O Olatunji1, Benjamin K Talom2, Ena C Oboh3
1Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA.
American journal of clinical oncology
|November 11, 2025
概括
患者导航显示了改善撒哈拉以南非洲 (SSA) 癌症护理的希望. 这一战略是可行的和有益的,但需要战略投资,以实现可持续的扩大规模,并克服融资障碍.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健管理的管理
背景情况:
- 癌症在撒哈拉以南非洲 (SSA) 是一个重大的健康挑战.
- 患者导航是解决癌症护理差异的一个新兴策略.
- 患者在SSA导航的范围和影响仍未得到充分研究.
研究的目的:
- 综合地绘制SSA癌症护理患者导航干预措施的现有文献.
- 确定这些干预措施的特点,结果和实施因素.
- 评估患者导航在SSA环境中的可行性,可接受性和益处.
主要方法:
- 使用标准化的三步搜索策略进行了范围审查.
- 符合条件的研究重点是SSA内的癌症护理患者导航干预措施.
- 数据提取涵盖了研究,参与者,导航员特征,结果以及实施障碍/促进者.
主要成果:
- 包括22项研究,详细介绍了10个SSA国家的20项干预措施.
- 大多数研究都是描述性的,重点关注治疗阶段的乳腺癌和宫癌.
- 导航者的角色包括教育,心理社会支持,护理协调和障碍减轻.
结论:
- 患者导航是可行的,可接受的,并有利于癌症患者在SSA.
- 资金有限是这些干预措施可持续性的关键障碍.
- 战略投资对于扩大患者导航以改善区域癌症结果至关重要.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.7K
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
478
相关概念视频
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
